Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population
NCT ID: NCT02772354
Last Updated: 2016-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
124 participants
INTERVENTIONAL
2016-04-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
NCT04770051
Cardiac RadiothErapy for VEntricular Tachycardia II
NCT06744530
Non-invasive Ablation of Ventricular Tachycardia
NCT03601832
Stereotactic Non-invasive Ablation of Ventricular Tachycardia
NCT03819504
Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia
NCT07017855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ablation
Standard radiosurgery ablation of premature ventricular complexes using navigation system.
Radiofrequency catheter ablation
Biosense Webster: NAVI-STAR ThermoCool, NAVI-STAR® RMT ThermoCool
NAVI-STAR® RMT ThermoCool
Control
Antiarrhythmic therapy of premature ventricular complexes according to the guidlines
Metoprolol
Antiarrhythmic therapy of premature ventricular complexes
Metoprolol 12-50 mg
Verapamil
Verapamil 20-240 mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiofrequency catheter ablation
Biosense Webster: NAVI-STAR ThermoCool, NAVI-STAR® RMT ThermoCool
Metoprolol
Antiarrhythmic therapy of premature ventricular complexes
Metoprolol 12-50 mg
Verapamil
Verapamil 20-240 mg
NAVI-STAR® RMT ThermoCool
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
7 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meshalkin Research Institute of Pathology of Circulation
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research Medical University
Moscow, , Russia
State Research Institute of CIrculation Pathology Novosibirsk, Russian Federation
Novosibirsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sergey Termosesov, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILM511
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.